SEARCH

SEARCH BY CITATION

References

  • [1]
    Deresinski, S (1995) Infections in the diabetic patient: Strategies for the clinician. Infect. Dis. Rep. 1, 112.
  • [2]
    Carton, J.A, Maradona, J.A, Nuno, F.J, Fernandez-Alvarez, R, Perez-Gonzalez, F, Asensi, V (1992) Diabetes mellitus and bacteraemia: A comparative study between diabetic and non-diabetic patients. Eur. J. Med. 1, 281287.
  • [3]
    Lederman, M.M, Schiffman, G.A, Rodman, H.M (1981) Pneumococcal immunization in adults. Diabetes 30, 119121.
  • [4]
    Beam, T.R.J, Crigler, E.D, Goldman, J.R, Schifmann, G (1980) Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics. J. Am. Med. Assoc. 244, 26412644.
  • [5]
    Li Volti, S, Caruso-Nicoletti, M, Biazzo, F, Sciacca, A, Mandara, G, Mancuso, M, Mollica, F (1998) Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus. Arch. Dis. Child. 78, 5457.
  • [6]
    Moutschen, M.P, Scheen, A.J, Lefebvre, P.J (1992) Impaired immune responses in diabetes mellitus: Analysis of the factors and mechanisms involved in relevance to the increased susceptibility of diabetic patients to specific infections. Diabetes Metab. 18, 187201.
  • [7]
    Casey, J.I, Heeter, B.J, Klyshevich, K.A (1977) Impaired response of lymphocytes of diabetic subjects to antigen of Staphylococcus aureus. J. Infect. Dis. 136, 495501.
  • [8]
    Maccuish, A.C, Urbaniak, S.J, Campbell, C.J, Duncan, L.J.P, Irvine, W (1974) Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetics. Diabetes 23, 708712.
  • [9]
    Plouffe, J.F, Silva, J, Fekety, F.R.J, Allen, J.L (1978) Cell-mediated immunity in diabetes mellitus. Infect. Immun. 21, 425429.
  • [10]
    Vergani, D, Johnston, C, B-Abdullah, N, Barnett, A.H (1983) Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes. Br. Med. J. 286, 926928.
  • [11]
    Mysliwska, J, Zorena, K, Bakowska, A, Skuratowicz-Kubica, A, Mysliwski, A (1998) Significance of tumor necrosis factor-α in patients with long-standing type-1 diabetes mellitus. Horm. Metab. Res. 30, 158161.
  • [12]
    Pickup, J.C, Crook, M.A (1998) Is type II diabetes mellitus a disease of the innate immune system. Diabetologia 41, 12411248.
  • [13]
    Zozulinska, D, Majchrzak, A, Sobieska, M, Wiktorowicz, K, Wierusz-Wysocka, B (1999) Serum interleukin-8 level is increased in diabetic patients. Diabetologia 42, 117118.
  • [14]
    Mooradian, A.D, Reed, R.L, Meredith, K.E, Scuderi, P (1991) Serum levels of tumor necrosis factor and IL1α and IL-1β in diabetic patients. Diabetes Care 14, 6365.
  • [15]
    Ohno, Y, Aoki, N, Nishimura, A (1993) In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-α in insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 77, 10721077.
  • [16]
    Ziegler-Heitbrock, H.W.L, Wedel, A, Schraut, W, Strobel, M, Wendelgass, P, Sternsdorf, T, Bauerle, P.A, Haas, J.G, Riethmuller, G (1994) Tolerance to lipopolysaccharide involves mobilization of nuclear factor kB with predominance of p50 homodimers. J. Biol. Chem. 269, 1700117004.
  • [17]
    Morohoshi, M, Fujisawa, K, Uchimura, I, Numano, F (1995) The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. Ann. NY Acad. Sci. 748, 562570.
  • [18]
    Reinhold, D, Ansorge, S, Schleicher, E.D (1996) Elevated glucose levels stimulate transforming growth factor-b1 (TGF-B1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Horm. Metab. Res. 28, 267270.
  • [19]
    Stehouwer, C, Lambert, J, Donker, A, van Hinsbergh, V.W.M (1997) Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc. Res. 34, 5568.
  • [20]
    Vlassara, H, Brownlee, M, Manogue, K.R, Dinarello, C.A, Pasagian, A (1988) Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 240, 15461548.
  • [21]
    Imani, F, Horii, Y, Suthanthiran, M, Skolnik, E.Y, Makita, Z, Sharma, V, Sehajpal, P, Vlassara, H (1993) Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: Role in tissue remodeling. J. Exp. Med. 178, 21652172.
  • [22]
    Wahl, P.W, Savage, P.J, Psaty, B.M, Orchard, T.J, Robbins, J.A, Tracy, R.P (1998) Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet 352, 10121015.
  • [23]
    Hostetter, M.K (1990) Perspectives in diabetes. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 39, 271275.
  • [24]
    Geerlings, S.E, Brouwer, E.C, Gaastra, W, Verhoef, J, Hoepelman, A.I.M (1999) The effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: Studies using urine from diabetics and non-diabetics. J. Med. Microbiol. 48, 535539.
  • [25]
    Tater, D, Tepaut, B, Bercovici, J.P, Youinou, P (1987) Polymorphonuclear cell derangements in type I diabetes. Horm. Metab. Res. 19, 642647.
  • [26]
    Tan, J.S, Anderson, J.L, Watanakunakorn, C, Phair, J.P (1975) Neutrophil dysfunction in diabetes mellitus. J. Lab. Clin. Med. 85, 2633.
  • [27]
    Andersen, B, Goldsmith, G.H, Spagnuolo, P.J (1988) Neutrophil adhesive dysfunction in diabetes mellitus; the role of cellular and plasma factors. J. Lab. Clin. Med. 111, 275285.
  • [28]
    Bloomgarden, Z.T (1998) Endothelial dysfunction, neuropathy and the diabetic foot, diabetic mastopathy, and erectile dysfunction. Diabetes Care 21, 183189.
  • [29]
    Zargar, A.H, Shah, N.A, Masoodi, S.R, Laway, B.A, Dar, F.A, Khan, A.R, Sofi, F.A, Wani, A.I (1998) Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgrad. Med. J. 74, 665668.
  • [30]
    Wellinghausen, N, Schromm, A.B, Seydel, U, Brandenburg, K, Luhm, J, Kirchner, H, Rink, L (1996) Zinc enhances lipopolysaccharide-induced monkine secretion by alteration of fluidity state of lipopolysaccharide. J. Immunol. 157, 31393145.
  • [31]
    Delamaire, M, Maugendre, D, Moreno, M, Le Goff, M, Allannic, H, Genetet, B (1997) Impaired leucocyte functions in diabetic patients. Diabetic Med. 14, 2934.
  • [32]
    Mowat, A.G, Baum, J (1971) Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. New Engl. J. Med. 284, 621627.
  • [33]
    Balasoiu, D, van Kessel, K.C, van Kats-Renaud, H.J, Collet, T.J, Hoepelman, A.I (1997) Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care 20, 392395.
  • [34]
    Bagdade, J.D, Stewart, M, Walters, E (1978) Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 27, 677681.
  • [35]
    Bagdade, J.D, Walters, E (1980) Impaired granulocyte adherence in mildly diabetic patients. Effects of tolazamide treatment. Diabetes 29, 309311.
  • [36]
    Marhoffer, W, Stein, M, Maeser, E, Federlin, K (1992) Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 15, 256260.
  • [37]
    Gin, H, Brottier, E, Aubertin, J (1984) Influence of glycaemic normalisation by an artificial pancreas on phagocytic and bactericidal functions of granulocytes in insulin dependent diabetic patients. J. Clin. Pathol. 37, 10291031.
  • [38]
    Saeed, F, Castle, G.E (1998) Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: Implications for diabetic susceptibility to infections. Clin. Diagn. Lab. Immunol. 5, 740743.
  • [39]
    Shah, S.V, Wallin, J.D, Eilen, S.D (1983) Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J. Clin. Endocrinol. Metab. 57, 402409.
  • [40]
    Katz, S, Klein, B, Elian, I, Fishman, P, Djaldetti, M (1983) Phagocytotic activity of monocytes from diabetic patients. Diabetes Care 6, 479482.
  • [41]
    Schaeffer, A.J, Jones, J.M, Dunn, J.K (1981) Association of in vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections. New Engl. J. Med. 304, 10621066.
  • [42]
    Aly, F.Z, Blackwell, C.C, Mackenzie, D.A.C, Weir, D.M, Clarke, B.F (1992) Factors influencing oral carriage of yeasts among individuals with diabetes mellitus. Epidemiol. Infect. 109, 507518.
  • [43]
    Cameron, B.J, Douglas, L.J (1996) Blood group glycolipids as epithelial cell receptors for Candida albicans. Infect. Immun. 64, 891896.
  • [44]
    Weinmeister, K.D, Dal Nogare, A.R (1994) Buccal cell carbohydrates are altered during critical illness. Am. J. Respir. Crit. Care Med. 150, 131134.
  • [45]
    Darwazeh, A.M.G, Lamey, P.J, Samaranayake, L.P, MacFarlane, T.W, Fisher, B.M, MacRury, S.M, Maccuish, A.C (1990) The relationship between colonisation, secretor status and in vitro adhesion of Candida albicans to buccal epithelial cells from diabetics. J. Med. Microbiol. 33, 4349.